2017 ASCO Educational Book

2017 ASCO Educational BookEl 2017 ASCO Educational Book es una colección de escritos elaborados por personal docente de la Reunión Anual de la ASCO (Sociedad americana de Oncología clínica) y líderes invitados de otras reuniones de la prestigiosa sociedad. Publicados anualmente, cada volumen destaca la investigación más convincente y el desarrollo del campo multidisciplinario de la Oncología, por lo que sirve como un recurso académico trascendental.

Estos artículos tratan temas en áreas de la Oncología como la cirugía , la radioterapia el  manejo de los síntomas, la investigación, perspectivas mundiales de la especialidad, Patología e Inmunoncología, entre otros.

Este libro es revisado por expertos en los diversos campos de la Oncología y la investigación del cáncer para garantizar la más alta integridad y calidad científica. El desarrollo del volumen está dirigido por un Consejo Editorial que supervisa todos los aspectos de la creación de contenido y su revisión.

Temas presentados en este libro (en inglés)

Addressing the Survivorship Care Needs of Patients Receiving Extended Cancer Treatment

Adoptive T-Cell Therapy for Solid Tumors

Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers

Advances in the Treatment of Pediatric Bone Sarcomas

Age and Sex in Non-Hodgkin Lymphoma Therapy: It’s Not All Created Equal, or Is It?

American Society for Radiation Oncology 2016 Annual Meeting: Central Nervous System Abstracts

Bench-to-Bedside Approaches for Personalized Exercise Therapy in Cancer

Best Practices and Practical Nuances in the Treatment of Gastric Cancer in High-Risk Global Areas

Beyond Alkylating Agents for Gliomas: Quo Vadimus?

Biomarker Testing for Personalized Therapy in Lung Cancer in Low- and Middle-Income Countries

Biomarkers for Checkpoint Inhibition

Bone Sarcoma Pathology: Diagnostic Approach for Optimal Therapy

Breast Cancer After Childhood, Adolescent, and Young Adult Cancer: It’s Not Just About Chest Radiation

Breast Cancer in the Central Nervous System: Multidisciplinary Considerations and Management

Can Cancer Truths Be Told? Challenges for Medical Journalism

Cancer Care and Control as a Human Right: Recognizing Global Oncology as an Academic Field

Can Cancer Truths Be Told? Challenges for Medical Journalism

Cancer Care and Control as a Human Right: Recognizing Global Oncology as an Academic Field

Caring for the Older Population With Advanced Lung Cancer

Challenges in Opening and Enrolling Patients in Clinical Trials

Chronic Myeloid Leukemia: What Every Practitioner Needs to Know in 2017

Clinical Pathways and the Patient Perspective in the Pursuit of Value-Based Oncology Care

Collaborating With Advanced Practice Providers: Impact and Opportunity

Current Approaches to Mantle Cell Lymphoma: Diagnosis, Prognosis, and Therapies

Data Commons to Support Pediatric Cancer Research

Deploying Immunotherapy in Pancreatic Cancer: Defining Mechanisms of Response and Resistance

Diagnosis and Treatment of Prostate Cancer: What Americans Can Learn From International Oncologists

Endometrial Cancer: Is This a New Disease?

Established and Novel Prognostic Biomarkers in Multiple Myeloma

European/U.S. Comparison and Contrasts in Ovarian Cancer Screening and Prevention in a High-Risk Population

Evolving Treatment Paradigm in Metastatic Renal Cell Carcinoma

Fertility, Cardiac, and Orthopedic Challenges in Survivors of Adult and Childhood Sarcoma

For Our Patients, for Ourselves: The Value of Personal Reflection in Oncology

Future Genetic/Genomic Biomarker Testing in Non–Small Cell Lung Cancer

Gastric Cancer in Asia: Unique Features and Management

Gastric Cancer in Southern Europe: High-Risk Disease

Global Health Initiatives of the International Oncology Community

Health Disparities and the Global Landscape of Lymphoma Care Today

Hematologic Malignancies: Plasma Cell Disorders

Higher-Level Pathway Objectives of Epigenetic Therapy: A Solution to the p53 Problem in Cancer

How Should We Intervene on the Financial Toxicity of Cancer Care? One Shot, Four Perspectives

Immunotherapy for Esophageal and Gastric Cancer

Improving Cancer Care Through the Patient Experience: How to Use Patient-Reported Outcomes in Clinical Practice

Improving Quality and Value of Cancer Care for Older Adults

Integration of Genomics Into Treatment: Are We There Yet?

Lifestyle Interventions to Improve Cardiorespiratory Fitness and Reduce Breast Cancer Recurrence

Making the Case for Improving Oncology Workforce Diversity

Managing Resistance to EFGR- and ALK-Targeted Therapies

Mastering Resilience in Oncology: Learn to Thrive in the Face of Burnout

Metabolic Alterations in Cancer and Their Potential as Therapeutic Targets

Minimizing Minimally Invasive Surgery for Endometrial Carcinoma

More Medicine, Fewer Clicks: How Informatics Can Actually Help Your Practice

Myeloma in Elderly Patients: When Less Is More and More Is More

New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy

New Developments and Challenges in Rare Genitourinary Tumors: Non-Urothelial Bladder Cancers and Squamous Cell Cancers of the Penis

New Insight Into the Biology, Risk Stratification, and Targeted Treatment of Myelodysplastic Syndromes

Novel Targeted Agents and Immunotherapy in Breast Cancer

Novel Therapeutics in Acute Myeloid Leukemia

Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy

Optimal Management of Early and Advanced HER2 Breast Cancer

Optimizing Breast Cancer Adjuvant Radiation and Integration of Breast and Reconstructive Surgery

Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives

Pancreatic Adenocarcinoma: Improving Prevention and Survivorship

Pathology Issues in Thoracic Oncology: Histologic Characterization and Tissue/Plasma Genotyping May Resolve Diagnostic Dilemmas

Personalizing Adjuvant Therapy for Stage II/III Colorectal Cancer

Personalizing Therapy for Metastatic Prostate Cancer: The Role of Solid and Liquid Tumor Biopsies

Perspectives on the Use of Clinical Pathways in Oncology Care

Pharmacokinetic/Pharmacodynamic Modeling for Drug Development in Oncology

Practice Model for Advanced Practice Providers in Oncology

Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting

Precision Oncology: Who, How, What, When, and When Not?

Role of Chemotherapy and Targeted Therapy in Early-Stage Non–Small Cell Lung Cancer

Screening and Treating Prostate Cancer in the Older Patient: Decision Making Across the Clinical Spectrum

Social Media and Mobile Technology for Cancer Prevention and Treatment

Social Media for Networking, Professional Development, and Patient Engagement

Standard and Genomic Tools for Decision Support in Breast Cancer Treatment

Strategies to Maximize Patient Participation in Clinical Trials

Systemic Therapy Options for Patients With Unresectable Melanoma

Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches

Systemic Therapy for Non–Clear Cell Renal Cell Carcinoma

The Current Landscape of Early Drug Development for Patients With Sarcoma

The Oncology Care Model: Perspectives From the Centers for Medicare & Medicaid Services and Participating Oncology Practices in Academia and the Community

The Promise of Immunotherapy in the Treatment of Hepatocellular Carcinoma

The Road of Mentorship

The Road to Addressing Noncommunicable Diseases and Cancer in Global Health Policy

Therapeutic Bone-Modifying Agents in the Nonmetastatic Breast Cancer Setting: The Controversy and a Value Assessment

Thinking Differently in Global Health in Oncology Using a Diagonal Approach: Harnessing Similarities, Improving Education, and Empowering an Alternative Oncology Workforce

Tissue-Agnostic Drug Development

Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?

Understanding the New WHO Classification of Lymphoid Malignancies: Why It’s Important and How It Will Affect Practice

Using the New ASCO Clinical Practice Guideline for Palliative Care Concurrent With Oncology Care Using the TEAM Approach

Value-Based Medicine and Integration of Tumor Biology

Wedge Resection Versus Anatomic Resection: Extent of Surgical Resection for Stage I and II Lung Cancer

Whence High-Grade Serous Ovarian Cancer

mHealth: Mobile Technologies to Virtually Bring the Patient Into an Oncology Practice